Literature DB >> 27312464

The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis.

A Kucuk1, A Uğur Uslu2, A Icli3, E Cure4, S Arslan3, K Turkmen3, A Toker3, M Kayrak3.   

Abstract

OBJECTIVES: In ankylosing spondylitis (AS) patients, cardiac and vascular involvement may manifest as atherosclerosis and coronary artery disease. Systemic inflammation, oxidative stress, increased low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol constitute a significant risk for atherosclerosis. This study investigated the relationship between carotid intima-media thickness (CIMT), LDL/HDL ratio, total oxidant status (TOS; an indicator of oxidative stress) and ischemic modified albumin (IMA; an ischemic marker in AS patients). PATIENTS AND METHODS: Sixty AS patients were diagnosed using the Modified New York Criteria; 54 age- and gender-matched participants were included as controls. CIMT, LDL/HDL ratio, TOS and IMA were measured using the most appropriate methods.
RESULTS: IMA was higher in AS patients compared to controls (p < 0.0001). TOS was also increased in AS patients (p = 0.005); as was CIMT (p < 0.0001). The LDL/HDL ratio was also greater in AS patients compared to controls (p = 0.047). A positive correlation was found between CIMT and LDL/HDL ratio among AS patients.
CONCLUSION: Elevated CIMT, IMA and TOS levels suggest an increased risk of atherosclerotic heart disease in AS patients. The LDL/HDL ratio was higher in AS patients compared to controls, and there was a correlation between LDL/HDL ratio and CIMT, albeit statistically weak. Therefore, the LDL/HDL ratio is not a reliable marker to predict atherosclerotic heart disease in AS patients.

Entities:  

Keywords:  Ankylosing spondylitis; Atherosclerosis; Dyslipidemias; Ischemia-modified albumin; Oxidative Stress

Mesh:

Substances:

Year:  2017        PMID: 27312464     DOI: 10.1007/s00393-016-0092-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  40 in total

Review 1.  Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.

Authors:  Abdellah El Maghraoui
Journal:  Eur J Intern Med       Date:  2011-07-13       Impact factor: 4.487

2.  Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.

Authors:  Yigang Zhong; Ningfu Wang; Haiying Xu; Xuwei Hou; Peng Xu; Zhanlin Zhou
Journal:  Coron Artery Dis       Date:  2012-12       Impact factor: 1.439

3.  Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation?

Authors:  Renato Leandro Mattar Valente; Jamil Mattar Valente; Gláucio Ricardo Werner de Castro; Adriana Fontes Zimmermann; Sonia Cristina de Magalhães Souza Fialho; Ivânio Alves Pereira
Journal:  Rev Bras Reumatol       Date:  2013 Sep-Oct

4.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

Authors:  D Bar-Or; E Lau; J V Winkler
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

5.  Carotid intima-media thickness (CIMT) and carotid plaques in young Nepalese patients with angiographically documented coronary artery disease.

Authors:  Yuba Raj Limbu; Rajib Rajbhandari; Ranjit Sharma; Satish Singh; Dipak Limbu; Chandra Mani Adhikari; Dipankar Prajapati
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

6.  Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis.

Authors:  Michele R Leitemperguer; Etiane Tatsch; Helena Kober; José Antônio M De Carvalho; Rafael N Moresco; José Edson P Da Silva
Journal:  Clin Lab       Date:  2014       Impact factor: 1.138

Review 7.  The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases.

Authors:  Corina Şerban; Simona Drăgan
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.

Authors:  Carlos Gonzalez-Juanatey; Tomas R Vazquez-Rodriguez; Jose A Miranda-Filloy; Trinidad Dierssen; Ines Vaqueiro; Ricardo Blanco; Javier Martin; Javier Llorca; Miguel A Gonzalez-Gay
Journal:  Medicine (Baltimore)       Date:  2009-11       Impact factor: 1.889

9.  Contribution of oxidative stress to endothelial dysfunction in hereditary hemorrhagic telangiectasia.

Authors:  Mirjana Jerkic; Michelle Letarte
Journal:  Front Genet       Date:  2015-02-13       Impact factor: 4.599

10.  Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Authors:  Peter P Toth; Angelo M Patti; Dragana Nikolic; Rosaria V Giglio; Giuseppa Castellino; Teresa Biancucci; Fabiana Geraci; Sabrina David; Giuseppe Montalto; Ali Rizvi; Manfredi Rizzo
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

View more
  11 in total

1.  Metabolic syndrome components and sudden sensorineural hearing loss: a case-control study.

Authors:  Mir Mohammad Jalali; Mahsa Nasimidoust Azgomi
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-24       Impact factor: 2.503

2.  Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.

Authors:  Erkan Cure; Abdullah Icli; Ali Ugur Uslu; Davut Sakiz; Medine Cumhur Cure; Rabia Aydogan Baykara; Fatma Yavuz; Sevket Arslan; Adem Kucuk
Journal:  Clin Rheumatol       Date:  2018-02-12       Impact factor: 2.980

3.  Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors.

Authors:  Aicha Ben Tekaya; Seif Boukriba; Ahmed Fendri; Leila Rouached; Olfa Saidane; Selma Bouden; Rawdha Tekaya; Kamel Ben Salem; Ines Mahmoud; Mizouni Habiba; Leila Abdelmoula
Journal:  RMD Open       Date:  2022-07

4.  Ischemic heart disease and ankylosing spondylitis-assessing the role of inflammation.

Authors:  Michal Vinker Shuster; Omer Gendelman; Shmuel Tiosano; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Clin Rheumatol       Date:  2018-02-22       Impact factor: 2.980

5.  Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Karolina Sieroń; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

6.  High-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU.

Authors:  Qin Wu; Xi Zhong; Min Fu; Hao Yang; Hong Bo; Xuelian Liao; Zhi Hu; Bo Wang; Zhongwei Zhang; Xiaodong Jin; Yan Kang
Journal:  BMC Gastroenterol       Date:  2020-05-27       Impact factor: 3.067

Review 7.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.

Authors:  James P C Coverdale; Kondwani G H Katundu; Amélie I S Sobczak; Swati Arya; Claudia A Blindauer; Alan J Stewart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-20       Impact factor: 4.006

8.  Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome.

Authors:  Ali Ugur Uslu; Yahya Sekin; Gulten Tarhan; Nuray Canakcı; Mehmet Gunduz; Mustafa Karagulle
Journal:  Clin Appl Thromb Hemost       Date:  2017-12-06       Impact factor: 2.389

9.  The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis

Authors:  Rabia Aydoğan Baykara; Adem Küçük; Ayça Tuzcu; Göksel Tuzcu; Erkan Cüre; Ali Uğur Uslu; Ahmet Omma
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

10.  Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis.

Authors:  Duygu Eryavuz Onmaz; Kevser Isik; Abdullah Sivrikaya; Sedat Abusoglu; İlknur Albayrak Gezer; Gulsum Abusoglu; Fatma Humeyra Yerlikaya; Ali Unlu
Journal:  Amino Acids       Date:  2021-07-17       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.